Cargando…
Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
BACKGROUND: Gliomas are the most common intracranial tumors and are classified as I–IV. Among them, glioblastoma multiforme (GBM) is the most common invasive glioma with a poor prognosis. New molecular biomarkers that can predict clinical outcomes in GBM patients must be identified, which will help...
Autores principales: | Yang, Ji’an, Wang, Long, Xu, Zhou, Wu, Liquan, Liu, Baohui, Wang, Junmin, Tian, Daofeng, Xiong, Xiaoxing, Chen, Qianxue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136556/ https://www.ncbi.nlm.nih.gov/pubmed/32296458 http://dx.doi.org/10.3389/fgene.2020.00253 |
Ejemplares similares
-
Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
por: Tang, Xiangjun, et al.
Publicado: (2020) -
Exploring the prognostic value of HK3 and its association with immune infiltration in glioblastoma multiforme
por: Yang, Yuling, et al.
Publicado: (2023) -
A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
por: Gao, Ming, et al.
Publicado: (2021) -
Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme
por: Sun, Ruohan, et al.
Publicado: (2021) -
A Novel Six-mRNA Signature Predicts Survival of Patients With Glioblastoma Multiforme
por: Liu, Zhentao, et al.
Publicado: (2021)